27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Why Is It Moving? Looking Into Why Celldex Therapeutics's Stock is Trading Lower Today
The Price And Volume Action In Celldex Therapeutics's Stock Today
Celldex Therapeutics (NASDAQ:CLDX) is currently down 34.36% to a price of $15.55. The stock's current volume for the day is 2.95 million, which is approximately 478.94% of its previous 30-day average volume of 616.13 thousand.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Celldex Therapeutics shares are trading lower after the company reported interim data from the company's ongoing, open label clinical trial of CDX-0159 in patients with antihistamine refractory cold contact urticaria and symptomatic dermographism.
Further Analysis of Recent Price Action
The moving average price of the stock over the past 50 days was $23.99 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $30.17 and as low as $1.56.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!